rejuvant life tabs
rejuvant life tabs

Feature articles

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Cambrian Biopharma – Juliette Han Q&A

Longevity biotech exclusive Q&A with Cambrian Biopharma's Chief Operating Officer. Recently we reported on Cambrian Biopharma, a New York-based biotech which raised $60 million to...

Increasing life expectancy – the rise of longevity

The human body can be equated to a very intricate machine, which over time begins to falter – what does this mean for the...

Latest news

Cambrian Biopharma – Juliette Han Q&A

Longevity biotech exclusive Q&A with Cambrian Biopharma's Chief Operating Officer. Recently we reported on Cambrian Biopharma, a New York-based biotech which raised $60 million to...

Increasing life expectancy – the rise of longevity

The human body can be equated to a very intricate machine, which over time begins to falter – what does this mean for the...

Shining a Sheekey light on science

Introducing Eleanor Sheekey and The Sheekey Science Show – taking science communication to a whole new level. The Sheekey Science Show looks at all sorts of science...

We are what we eat: Jim Mellon exclusive

Longevity, biotech, investment, sustainability and ethics: Jim Mellon's new book, MOO'S LAW, addresses the opportunities and challenges of our need for protein. Getting time with...

2021 hits the longevity ground running

Highlights from longevity research, trials and funding in January 2021 Hundreds of companies are working to develop treatments to slow down aging and increase healthy...

New Buck Institute study is treasure trove for longevity research

Compound that extends lifespan in worms also slows bone loss in mice. Scientists at the Buck Institute for Research on Aging conducted a longitudinal and functional study...

Juvenescence (1): from strength to strength in R&D and investment firepower

Juvenescence's Greg Bailey on transformative scientific opportunities, immuno-resilience, modifying aging and funding. Continuing our series of interviews with our Advisory Panel members, we spoke to Greg...
Rejuvant
Supps report ad middle

Let’s initiate trials of potential geroprotective therapies

Dr Lynne Cox explains the importance of geroprotectors – especially during COVID-19. This month The Lancet launches its own journal on Longevity, publishing clinically-focused Longevity and...

COVID-19: Leading clinician calls for focus on the biology of aging

Dr Nir Barzilai predicts that rapamycin could decrease severity of coronavirus in the elderly by 50%. Longevity.Technology: When it comes to the world of Longevity...

Tina Woods: Prevention is vital for Longevity

Longevity International’s Tina Woods tells us how the Longevity industry is releasing us from being trapped in the cycle of ill health and chronic...

Longevity FinTech: a new contract between finance and aging

Academic proposes that FinTech and InsurTech can be a key enabler of new financial approaches for older people. Ira Sobel is the founder of FinTech...

Latest news

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Longevity pharmacology “promises to revolutionize medicine”

Leading biogerontologist João Pedro de Magalhães says that longevity pharmacology has come of age, and discusses rapamycin, Calico and human trials. The longevity space is...

Cambrian Biopharma – CEO James Peyer Q&A

Longevity biotech exclusive Q&A with Cambrian Biopharma's CEO – hallmarks of aging and classifying aging as a disease. Dr James Peyer is Cambrian's CEO and...
Rejuvant

You might also like

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...
Supps report ad middle